Skip to main content
Clinical Trials/CTRI/2023/10/059323
CTRI/2023/10/059323
Not Yet Recruiting
Phase 4

A retrospective, multicentre, observational registry in patients treated with Myval™ Transcatheter Heart Valve System in real-world settings. - Myval THV Registry

Meril Diagnostics Private Limited0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Meril Diagnostics Private Limited
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Pms

Investigators

Sponsor
Meril Diagnostics Private Limited

Eligibility Criteria

Inclusion Criteria

  • Patients treated with the Myval THV system for the following conditions:
  • Symptomatic heart disease due to failure (stenosed, insufficient, or
  • combined) of a surgical bioprosthetic aortic valve or mitral valve
  • Symptomatic heart disease due to failure of native bicuspid aortic
  • Symptomatic heart disease due to failure of the pulmonic valve
  • Patients with calcific native mitral valve stenosis with mitral annular
  • calcification
  • Patients with failing surgical rings in the mitral position with mitral
  • regurgitation or stenosis
  • Patients who underwent tricuspid valve replacement (valve\-in\-valve)

Exclusion Criteria

  • As this is a retrospective review of data, there are no formal exclusion criteria for this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials